These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 25341346)

  • 1. [Effects of sulfonylureas on patients with type 2 diabetes and acute nonlacunar ischemic stroke].
    Chen DM; Yu YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 45(5):810-3. PubMed ID: 25341346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke.
    Kunte H; Schmidt S; Eliasziw M; del Zoppo GJ; Simard JM; Masuhr F; Weih M; Dirnagl U
    Stroke; 2007 Sep; 38(9):2526-30. PubMed ID: 17673715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-cause and cardiovascular mortality associated with sulphonylurea and metformin therapy in type 2 diabetes.
    Ioacara S; Guja C; Reghina A; Martin S; Sirbu A; Fica S
    Endocr Res; 2018 May; 43(2):97-105. PubMed ID: 29308936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas.
    Kunte H; Busch MA; Trostdorf K; Vollnberg B; Harms L; Mehta RI; Castellani RJ; Mandava P; Kent TA; Simard JM
    Ann Neurol; 2012 Nov; 72(5):799-806. PubMed ID: 23280795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfonylurea monotherapy and emergency room utilization among elderly patients with type 2 diabetes.
    Rajpathak SN; Fu C; Brodovicz K; Engel SS; Heaton PC
    Diabetes Res Clin Pract; 2015 Sep; 109(3):507-12. PubMed ID: 26123984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
    Mamza J; Mehta R; Donnelly R; Idris I
    Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression to insulin for patients with diabetes mellitus using the Texas Medicaid database.
    Rascati KL; Richards KM; Lopez D; Cheng LI; Wilson JP
    Clin Ther; 2011 Dec; 33(12):2016-20. PubMed ID: 22101160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy.
    Gitt AK; Bramlage P; Schneider S; Tschöpe D
    Cardiovasc Diabetol; 2015 Feb; 14():13. PubMed ID: 25645672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of vildagliptin relative to sulfonylurea as dual therapy with metformin (or as monotherapy) in Muslim patients with type 2 diabetes fasting during Ramadan in the Middle East: the VIRTUE study.
    Hassoun AA; Al-Arouj M; Ibrahim M
    Curr Med Res Opin; 2017 Jan; 33(1):161-167. PubMed ID: 27684469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Distribution of Prescription for Sulfonylureas in Patients with Type 2 Diabetes According to Cardiovascular Risk Factors Within a Canadian Primary Care Setting.
    Farahani P; Khan S; Oatway M; Dziarmaga A
    J Popul Ther Clin Pharmacol; 2015; 22(3):e228-36. PubMed ID: 26567749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone as monotherapy or in combination with sulfonylurea or metformin enhances insulin sensitivity (HOMA-S or QUICKI) in patients with type 2 diabetes.
    Tan MH; Glazer NB; Johns D; Widel M; Gilmore KJ
    Curr Med Res Opin; 2004 May; 20(5):723-8. PubMed ID: 15140339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany.
    Göke R; Gruenberger JB; Bader G; Dworak M
    Curr Med Res Opin; 2014 May; 30(5):785-9. PubMed ID: 24328429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazolidinedione addition reduces the serum retinol-binding protein 4 in type 2 diabetic patients treated with metformin and sulfonylurea.
    Lin KD; Chang YH; Wang CL; Yang YH; Hsiao PJ; Li TH; Shin SJ
    Transl Res; 2008 Jun; 151(6):309-14. PubMed ID: 18514142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence, persistence, and treatment discontinuation with sitagliptin compared with sulfonylureas as add-ons to metformin: A retrospective cohort database study.
    Bloomgarden ZT; Tunceli K; Liu J; Brodovicz KG; Mavros P; Engel SS; Radican L; Chen Y; Rajpathak S; Qiu Y; Brudi P; Fonseca V
    J Diabetes; 2017 Jul; 9(7):677-688. PubMed ID: 27531167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary albumin excretion with sitagliptin compared to sulfonylurea as add on to metformin in type 2 diabetes patients with albuminuria: A real-world evidence study.
    Goldshtein I; Karasik A; Melzer-Cohen C; Engel SS; Yu S; Sharon O; Brodovicz K; Gadir N; Katzeff HL; Radican L; Chodick G; Shalev V; Tunceli K
    J Diabetes Complications; 2016; 30(7):1354-9. PubMed ID: 27320183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.
    Ou SM; Shih CJ; Chao PW; Chu H; Kuo SC; Lee YJ; Wang SJ; Yang CY; Lin CC; Chen TJ; Tarng DC; Li SY; Chen YT
    Ann Intern Med; 2015 Nov; 163(9):663-72. PubMed ID: 26457538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus--a retrospective nationwide study.
    Mogensen UM; Andersson C; Fosbøl EL; Schramm TK; Vaag A; Scheller NM; Torp-Pedersen C; Gislason G; Køber L
    Diabetes Obes Metab; 2014 Oct; 16(10):1001-8. PubMed ID: 24827939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database.
    Rascati K; Richards K; Lopez D; Cheng LI; Wilson J
    Diabetes Obes Metab; 2013 Oct; 15(10):901-5. PubMed ID: 23531154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study.
    Horsdal HT; Mehnert F; Rungby J; Johnsen SP
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):717-25. PubMed ID: 21536457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment adherence with vildagliptin compared to sulphonylurea as add-on to metformin in Muslim patients with type 2 diabetes mellitus fasting during Ramadan.
    Hanif W; Malik W; Hassanein M; Kamal A; Geransar P; Andrews C; Azam M; Barnett AH
    Curr Med Res Opin; 2013 Jul; 29(7):807-11. PubMed ID: 23659561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.